TABLE 3.

Estimates of the daily dose dispensed (DDD) for the primary antipsychotic (in mg per day).

Primary antipsychotic	N	Mean DDD (SD)	Median DDD	Min-Max DDD
Risperidone	2,661	2.82 (2.25)	2.16	0.18−34.29
Cyamemazine	2,581	56.32 (63.54)	38.46	6.74−1,666.67
Olanzapine	1,636	9.68 (5.84)	8.21	0.89−52.5
Tiapride	1,213	170.76 (122.04)	143.75	19.11−2,500
Haloperidol	1,036	4.35 (4.78)	2.35	0.19−38.62
Aripiprazole	896	10.38 (7.25)	8.7	0.85−105
Sulpiride	829	101.35 (82.05)	86.44	12.3−1,033.86
Amisulpride	649	294.07 (285.96)	175.9	38.96−1,794.39
Quetiapine	518	246.13 (209.85)	168.22	18.52−1,028.57
Loxapine	362	70.93 (82.11)	40.54	6.82−40.54
Levomepromazine	348	61.51 (64.12)	37.64	6.7−37.64
Clozapine	179	183.44 (206.08)	60.96	5.37−809.64
Pipamperone	170	64.06 (38.66)	53.74	11.32−252.63
Zuclopenthixol	156	25.6 (29.29)	15.38	4.48−207.3
Chlorpromazine	111	85.55 (84.13)	62.89	7.81−754.89
Periciazine	103	33.26 (24.86)	29.78	2.06−151.05
Fluphenazine	88	20.65 (55.36)	4.44	1−345.05
Flupentixol	56	10.5 (17.58)	4.1	1−103.23
Pipotiazine	54	7.53 (12.02)	3.81	0.93−66.67
Paliperidone	52	3.11 (1.35)	2.84	0.62−7.14
Pimozide	51	3.21 (2.77)	2.2	0.3−13.04
Carpipramine	41	105.39 (57.85)	86.33	34.78−300
Penfluridol	6	5.94 (2.24)	5.29	2.94−8.89
Perphenazine	3	5.19 (1.91)	5	3.38−7.18

Figures were calculated from the dispensings performed between the inclusion date + 1 month and the date of the last dispensing (over a 12-month period).